Cattle bile but not bear bile or pig bile induces lipid profile changes and fatty liver injury in mice: Mediation by cholic acid

Journal of Toxicological Sciences

Volumn 37, Issue 1, 2012, Pages 105-121

  Watanabe, Shiro ^a   Tsuneyama, Koichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Bile acids; Cholesterol esters; Fatty liver; Monounsaturated fatty acids; Oleic acid; Triacylglycerols

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; CHOLIC ACID; LIPID; MESSENGER RNA; MONOUNSATURATED FATTY ACID; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE; CATTLE BILE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID BLOOD LEVEL; FATTY LIVER; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; BOS; MUS; SUIDAE;

EID: 84856848533     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.37.105     Document Type: Article

References (53)

1. Achouri, Y., Hegarty, B.D., Allanic, D., Bécard, D., Hainault, I., Ferré, P. and Foufelle, F. (2005): Long chain fatty acyl-CoA synthetase 5 expression is induced by insulin and glucose: involvement of sterol regulatory element-binding protein-1c. Biochimie, 87, 1149-1455
2. Alger, H.M., Brown, J.M., Sawyer, J.K., Kelley, K.L., Shah, R., Wilson, M.D., Willingham, M.C. and Rudel, L.L. (2010): Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization. J. Biol. Chem., 285, 14267-14274
3. Anstee, Q.M. and Goldin, R.D. (2006): Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int. J. Exp. Pathol., 87, 1-16
4. Balan, V., Dickson, E.R., Jorgensen, R.A. and Lindor, K.D. (1994): Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis. Mayo Clin. Proc., 69, 923-929
5. Bligh, E.G. and Dyer, W.J. (1959): A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol., 37, 911-917
6. Bramlett, K.S., Yao, S. and Burris, T.P. (2000): Correlation of farnesoid X receptor coactivator recruitment and cholesterol 7-hydroxylase gene repression by bile acids. Mol. Genet. Metabol., 71, 609-615
7. Cariou, B. (2008): The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis. Diabetes Metab., 34, 685-691
8. Carubbi, F., Guicciardi, M.E., Concari, M., Loria, P., Bertolotti, M. and Carulli, N. (2002): Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. Biochim. Biophys. Acta, 1580, 31-39
9. Chen, W., Suruga, K., Nishimura, N., Gouda, T., Lam, V.N. and Yokogoshi, H. (2005): Comparative regulation of major enzymes in the bile acid biosynthesis pathway by cholesterol, cholate and taurine in mice and rats. Life Sci., 77, 746-757
10. Chiang, J.Y., Kimmel, R., Weinberger, C. and Stroup, D. (2000): Farnesoid X receptor responds to bile acids and represses cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription. J. Biol. Chem., 275, 10918-10924
11. Cohen-Solal, C., Parquet, M., Férézou, J., Sérougne, C. and Lutton, C. (1995): Effects of hyodeoxycholic acid and alphahyocholic acid, two 6 alpha-hydroxylated bile acids, on cholesterol and bile acid metabolism in the hamster. Biochim. Biophys. Acta, 1257, 189-197
12. Delzenne, N.M., Calderon, P.B., Taper, H.S. and Roberfroid, M.B. (1992): Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies. Toxicol. Lett., 61, 291-304
13. Desai, M.S., Mariscalco, M.M, Tawil, A., Vallejo, J.G. and Smith, C.W. (2008): Atherogenic diet-induced hepatitis is partially dependent on murine TLR4 J. Leukoc. Biol., 83, 1336-1344
14. Dutton, A.J., Hepburn, C. and Macdonald, D.W. (2011): A stated preference investigation into the Chinese demand for farmed vs. wild bear bile. PLoS One, 6, e21243.
15. Feng, Y., Siu, K., Wang, N., Ng, K.M., Tsao, S.W., Nagamatsu, T. and Tong, Y. (2009): Bear bile: dilemma of traditional medicinal use and animal protection. J. Ethnobiol. Ethnomed., 5, 2.
16. Fiorucci, S., Cipriani, S., Baldelli, F. and Mencarelli, A. (2010): Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. Prog. Lipid Res., 49, 171-185
17. Flowers, M.T. and Ntambi, J.M. (2008): Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism. Curr. Opin. Lipidol., 19, 248-256
18. Hara, A. and Radin, N. (1978): Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem., 90, 420-426
19. Heuman, D.M. (1989): Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J. Lipid. Res., 30, 719-730
20. Horton, J.D., Goldstein, J.L. and Brown, M.S. (2002): SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest., 109, 1125-1131
21. Ikemoto, S., Takahashi, M., Tsunoda, N., Maruyama, K., Itakura, H., Kawanaka, K., Tabata, I., Higuchi, M., Tange, T., Yamamoto, T. and Ezaki, O. (1997): Cholate inhibits high-fat diet-induced hyperglycemia and obesity with acyl-CoA synthetase mRNA decrease. Am. J. Physiol., 273, E37-45
22. Iwaki, T., Ishizaki, K., Kinoshita, S., Tanaka, H., Fukunari, A., Tsurufuji, M. and Imada, T. (2007): Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters. World J. Gastroenterol., 13, 5003-5008
23. Janowski, B.A., Grogan, M.J., Jones, S.A., Wisely, G.B., Kliewer, S.A., Corey, E.J. and Mangelsdorf, D.J. (1999): Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc. Natl. Acad. Sci. USA, 96, 266-271
24. Jeong, W.I., Jeong, D.H., Do, S.H., Kim, Y.K., Park, H.Y., Kwon, O.D., Kim, T.H. and Jeong, K.S. (2005): Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats. J. Vet. Med. Sci., 67, 235-242
25. Lee, J.H., Zhou, J. and Xie, W. (2008): PXR and LXR in hepatic steatosis: a new dog and an old dog with new tricks. Mol. Pharm., 5, 60-66
26. Lefebvre, P., Cariou, B., Lien, F., Kuipers, F. and Staels, B. (2009): Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev., 89, 147-191
27. Lehmann, J.M., Kliewer, S.A., Moore, L.B., Smith-Oliver, T.A., Oliver, B.B., Su, J.L., Sundseth, S.S., Winegar, D.A., Blanchard, D.E., Spencer, T.A. and Willson, T.M. (1997): Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem., 272, 3137-3140
28. Lepercq, P., Hermier, D., David, O., Michelin, R., Gibard, C., Beguet, F., Relano, P., Cayuela, C. and Juste, C. (2005): Increasing ursodeoxycholic acid in the enterohepatic circulation of pigs through the administration of living bacteria. Br. J. Nutr., 93, 457-469
29. Lew, J.L., Zhao, A., Yu, J., Huang, L., De Pedro, N., Peláez, F., Wright, S.D. and Cui, J. (2004): The farnesoid X receptor controls gene expression in a ligand-and promoter-selective fashion. J. Biol. Chem., 279, 8856-8861
30. Lima-Cabello, E., García-Mediavilla, M.V., Miquilena-Colina, M.E., Vargas-Castrillón, J., Lozano-Rodríguez, T., Fernández-Bermejo, M., Olcoz, J.L., González-Gallego, J., García-Monzón, C. and Sánchez-Campos, S. (2011): Enhanced expression of proinflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clin. Sci., 120, 239-250
31. Martin, IV., Schmitt, J., Minkenberg, A., Mertens, J.C., Stieger, B., Mullhaupt, B. and Geier, A. (2010): Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice. Biol. Chem., 391, 1441-1449
32. Miyazaki, M., Kim, Y.C., Gray-Keller, M.P., Attie, A.D. and Ntambi, J.M. (2000): The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J. Biol. Chem., 275, 30132-30138
33. Pols, T.W., Noriega, L.G., Nomura, M., Auwerx, J. and Schoonjans, K. (2011): The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. J. Hepatol., 54, 1263-1272
34. Prawitt, J., Abdelkarim, M., Stroeve, J.H., Popescu, I., Duez, H., Velagapudi, V.R., Dumont, J., Bouchaert, E., van Dijk, T.H., Lucas, A., Dorchies, E., Daoudi, M., Lestavel, S., Gonzalez, F.J., Oresic, M., Cariou, B., Kuipers, F., Caron, S. and Staels, B. (2011): Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes, 60, 1861-1871
35. Qiao, X., Ye, M., Pan, D.L., Miao, W.J., Xiang, C., Han, J. and Guo, D.A. (2011): Differentiation of various traditional Chinese medicines derived from animal bile and gallstone: simultaneous determination of bile acids by liquid chromatography coupled with triple quadrupole mass spectrometry. J. Chromatogr. A, 1218, 107-117
36. Roda, A., Piazza, F., Baraldini, M., Speroni, E., Guerra, M.C., Cerré, C. and Cantelli Forti, G. (1998): Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat. Hepatology, 27, 520-525
37. Schattenberg, J.M. and Galle, P.R. (2010): Animal models of nonalcoholic steatohepatitis: of mice and man. Dig. Dis., 28, 247-254
38. Sehayek, E., Ono, J.G., Duncan, E.M., Batta, A.K., Salen, G., Shefer, S., Neguyen, L.B., Yang, K., Lipkin, M. and Breslow, J.L. (2001): Hyodeoxycholic acid efficiently suppresses atherosclerosis formation and plasma cholesterol levels in mice. J. Lipid. Res., 42, 1250-1256
39. Song, P., Zhang, Y. and Klaassen, C.D. (2011): Dose-response of five bile acids on serum and liver bile acid concentrations and hepatotoxicty in mice. Toxicol. Sci., 123, 359-367
40. Spady, D.K. and Cuthbert, J.A. (1992): Regulation of hepatic sterol metabolism in the rat. Parallel regulation of activity and mRNA for 7 alpha-hydroxylase but not 3-hydroxy-3-methylglutarylcoenzyme A reductase or low density lipoprotein receptor. J. Biol. Chem., 267, 5584-5591
41. Spady, D.K., Cuthbert, J.A., Willard, M.N. and Meidell, R.S. (1996): Feedback regulation of hepatic 7alpha-hydroxylase expression by bile salts in the hamster. J. Biol. Chem., 271, 18623-18631
42. Srivastava, R.A.K., Averna, M., Srivastava, N. and Pape, M.E. (2001): Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms. Int. J. Biochem. Cell Biol., 33, 1215-1226
43. Still, J. (2003): Use of animal products in traditional Chinese medicine: environmental impact and health hazards. Complement. Ther. Med., 11, 118-122
44. Uchida, K., Nomura, Y. and Takeuchi, N. (1980): Effects of cholic acid, chenodeoxycholic acid, and their related bile acids on cholesterol, phospholipid, and bile acid levels in serum, liver, bile, and feces of rats. J. Biochem., 87, 187-194
45. Ueno, K. and Okuyama, H. (1986): A high cholesterol/cholate diet induced fatty liver in spontaneously hypertensive rats. Lipids, 21, 475-480
46. Wang, D.Q., Tazuma, S., Cohen, D.E. and Carey, M.C. (2003): Feeding natural hydrophilic bile acids inhibits intestinal cholesterol absorption: studies in the gallstone-susceptible mouse. Am. J. Physiol. Gastrointest. Liver Physiol., 285, G494-502
47. Watanabe, M., Houten, S.M., Wang, L., Moschetta, A., Mangelsdorf, D.J., Heyman, R.A., Moore, D.D. and Auwerx, J. (2004): Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J. Clin. Invest., 113, 1408-1418
48. Watanabe, M., Houten, S.M., Mataki, C., Christoffolete, M.A., Kim, B.W., Sato, H., Messaddeq, N., Harney, J.W., Ezaki, O., Kodama, T., Schoonjans, K., Bianco, A.C. and Auwerx, J. (2006): Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature, 439, 484-489
49. Watanabe, M., Horai, Y., Houten, S.M., Morimoto, K., Sugizaki, T., Arita, E., Mataki, C., Sato, H., Tanigawara, Y., Schoonjans, K., Itoh, H. and Auwerx, J. (2011): Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J. Biol. Chem., 286, 26913-26920
50. Watanabe, S., Kamei, T., Tanaka, K., Kawasuji, K., Yoshioka, T. and Ohno, M. (2009): Roles of bile acid conjugates and phospholipids in in vitro activation of pancreatic lipase by bear bile and cattle bile. J. Ethnopharmacol., 125, 203-206
51. Woollett, L.A., Buckley, D.D., Yao, L., Jones, P.J., Granholm, N.A., Tolley, E.A., Tso, P. and Heubi, J.E. (2004): Cholic acid supplementation enhances cholesterol absorption in humans. Gastroenterology, 126, 724-731
52. Zhang, Y., Repa, J.J., Gauthier, K. and Mangelsdorf, D.J. (2001): Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J. Biol. Chem., 276, 43018-43024
53. Zhou, J., Febbraio, M., Wada, T., Zhai, Y., Kuruba, R., He, J., Lee, J.H., Khadem, S., Ren, S., Li, S., Silverstein, R.L. and Xie, W. (2008): Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology, 134, 556-567.